TABLE 2.
Summary of NPC1 variants reported in this study.
| Patient | cDNA | Protein | Chromosome position | Domain | Inheritance | gnomAD | Polyphen-2_HDIV Polyphen-2_HVAR | SIFT | PROVEAN | GERP++ | Revel | ACMG |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | c.2816C > T | p.Pro939Leu | 18:21,119,414 | CTD | maternal | - | Possibly damaging Benign | D | D | Conserved | D | VUS (PM2, PP3) |
| c.3749A > C | p.Tyr1250Ser | 18:21,113,324 | C-terminal | paternal | - | Probably damaging | D | D | Conserved | D | VUS (PM2, PP3) | |
| 2 | c.3229C > T | p.Arg1077* | 18:21,116,653 | CTD | paternal | 3.98*10–6 | - | - | - | Conserved | - | LP (PVS1, PM2) |
| c.1820G > T | p.Arg607Leu | 18:21,125,051 | MLD | maternal | - | Probably damaging | D | D | Conserved | D | VUS (PM2, PM3, PP3) |
NM_000,271.5 for cDNA, and NP_000,262.2 for protein sequence. CTD, C-terminal domain; MLD, Middle luminal Domain; D, Damaging; VUS, variant of uncertain significance; LP, Likely pathogenic